Literature DB >> 12930229

Antibacterial peptides: basic facts and emerging concepts.

H G Boman1.   

Abstract

Antibacterial peptides are the effector molecules of innate immunity. Generally they contain 15-45 amino acid residues and the net charge is positive. The cecropin type of linear peptides without cysteine were found first in insects, whilst the defensin type with three disulphide bridges were found in rabbit granulocytes. Now a database stores more than 800 sequences of antibacterial peptides and proteins from the animal and plant kingdoms. Generally, each species has 15-40 peptides made from genes, which code for only one precursor. The dominating targets are bacterial membranes and the killing reaction must be faster than the growth rate of the bacteria. Some antibacterial peptides are clearly multifunctional and an attempt to predict this property from the hydrophobicity of all amino acid side chains are given. Gene structures and biosynthesis are known both in the fruit fly Drosophila and several mammals. Humans need two classes of defensins and the cathelicidin-derived linear peptide LL-37. Clinical cases show that deficiencies in these peptides give severe symptoms. Examples given are morbus Kostmann and atopic allergy. Several antibacterial peptides are being developed as drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930229     DOI: 10.1046/j.1365-2796.2003.01228.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  259 in total

1.  Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide.

Authors:  Linda Tomasinsig; Marco Scocchi; Romina Mettulio; Margherita Zanetti
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

3.  Metabolism of small antimicrobial β(2,2)-amino acid derivatives by murine liver microsomes.

Authors:  Terkel Hansen; Morten K Moe; Trude Anderssen; Morten B Strøm
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-03-01       Impact factor: 2.441

Review 4.  Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.

Authors:  E Andrès
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-01       Impact factor: 3.267

5.  The multiple faces of host defence peptides and proteins.

Authors:  Artur Schmidtchen
Journal:  J Innate Immun       Date:  2012-05-22       Impact factor: 7.349

6.  SUMO mediating fusion expression of antimicrobial peptide CM4 from two joined genes in Escherichia coli.

Authors:  Jian Feng Li; Jie Zhang; Zhen Zhang; Chun Tao Kang; Shuang Quan Zhang
Journal:  Curr Microbiol       Date:  2010-07-17       Impact factor: 2.188

7.  Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli.

Authors:  M Moosazadeh Moghaddam; F Abolhassani; H Babavalian; R Mirnejad; K Azizi Barjini; J Amani
Journal:  Probiotics Antimicrob Proteins       Date:  2012-06       Impact factor: 4.609

8.  Structure--activity study of the antibacterial peptide fallaxin.

Authors:  Sandra L Nielsen; Niels Frimodt-Møller; Birthe B Kragelund; Paul R Hansen
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

9.  Experimental adaptation of Salmonella typhimurium to mice.

Authors:  Annika I Nilsson; Elisabeth Kugelberg; Otto G Berg; Dan I Andersson
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

10.  An insect symbiosis is influenced by bacterium-specific polymorphisms in outer-membrane protein A.

Authors:  Brian L Weiss; Yineng Wu; Jonathon J Schwank; Nicholas S Tolwinski; Serap Aksoy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.